Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP injection preparation viewing for knee osteoarthritis
NCT04111718Phase 4Active, not recruiting
- Sponsor
- ArthroBiologix Inc.
- Start
- Oct 2019
- Primary completion
- Dec 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by ArthroBiologix Inc. Primary endpoint: Visual Analog Scale Pain at 12 weeks. Started Oct 2019; status: active, not recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04111718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111718.